Sera Prognostics Inc (SERA)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$2.02+2.02%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · SERA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.1 | 0.0 |
| Total Revenues | 0.1 | 0.1 | 0.1 | 0.3 | — | — | — |
| Cost of Revenues | 0.2 | 0.2 | 0.1 | 0.2 | — | — | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 13.0 | 13.2 | 14.7 | 15.2 | 14.2 | 11.0 | 7.8 |
| Operating Income | (37.3) | (36.5) | (36.6) | (39.8) | (45.7) | (35.4) | (18.0) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.1 | — | — | — |
| Other Non-Operating Income / Expenses | 4.1 | 4.6 | 3.8 | 3.6 | 1.5 | 1.1 | (0.0) |
| EBT, Incl. Unusual Items | — | (31.9) | — | — | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (33.2) | (31.9) | (32.9) | (36.2) | (44.2) | (35.0) | (19.8) |
| Per Share | |||||||
| Basic EPS | (0.66) | (0.67) | (0.99) | (1.16) | (1.43) | (2.33) | (12.76) |
| Diluted EPS | (0.66) | (0.67) | (0.99) | (1.16) | (1.43) | (2.33) | (12.76) |
| Revenue per Share | 0.00 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 50.5 | 47.7 | 33.2 | 31.2 | 30.9 | 15.0 | 1.6 |
| Diluted Weighted Avg Shares | 50.5 | 47.7 | 33.2 | 31.2 | 30.9 | 15.0 | 1.6 |
| Supplemental | |||||||
| EBITDA | — | (35.7) | (35.8) | (38.9) | (44.9) | (34.7) | (17.1) |
| EBIT | (37.3) | (36.5) | (36.6) | (39.8) | (45.7) | (35.4) | (18.0) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.